Evidence map›Paper›PMID 35070356›Full record

ReviewFuture science OA2022

Extracellular vesicles: a promising cell-free therapy for cartilage repair.

Rizka Musdalifah Amsar, Christofora Hanny Wijaya, Ika Dewi Ana, Atik Choirul Hidajah, Hari Basuki Notobroto, Triati Dewi Kencana Wungu, Anggraini Barlian

Abstract readReview
In one paragraph

Review in Future science OA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Mesenchymal Stromal Cells for Aging Cartilage Regeneration: A Review.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rizka Musdalifah AmsarSchool of Life Science & Technology, Institut Teknologi Bandung, Bandung, West Java, 40132, Indonesia.ORCID https://orcid.org/0000-0002-3131-9968
Christofora Hanny WijayaDepartment of Food Science & Technology, Bogor Agricultural University, West Java, 16680, Indonesia.ORCID https://orcid.org/0000-0002-2938-7662
Ika Dewi AnaDepartment of Dental Biomedical Sciences, Faculty of Dentistry, Gadjah Mada University, Yogyakarta, 55281, Indonesia.ORCID https://orcid.org/0000-0001-9957-4247
Atik Choirul HidajahDepartment of Epidemiology Faculty of Public Health, Airlangga University, East Java, 60115, Indonesia.ORCID https://orcid.org/0000-0002-9797-1887
Hari Basuki NotobrotoDepartment of Biostatics & Population Faculty of Public Health, Airlangga University, East Java, 60115, Indonesia.ORCID https://orcid.org/0000-0002-3905-7413
Triati Dewi Kencana WunguNuclear Physics & Biophysics Research Group, Department of Physics, Faculty of Mathematics & Natural Sciences, Institut Teknologi Bandung, West Java, 40132, Indonesia.ORCID https://orcid.org/0000-0003-2429-3613
Anggraini BarlianSchool of Life Science & Technology, Institut Teknologi Bandung, Bandung, West Java, 40132, Indonesia.ORCID https://orcid.org/0000-0002-0826-3134

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few effective therapies for cartilage repair have been found as cartilage has a low regenerative capacity. Extracellular vesicles (EVs), including exosomes, are produced by cells and contain bioactive components such as nucleic acids, proteins, lipids and other metabolites that have potential for treating cartilage injuries. Challenges like the difficulty in standardizing targeted therapy have prevented EVs from being used frequently as a treatment option. In this review we present current studies, mechanisms and delivery strategies of EVs. Additionally, we describe the challenges and future directions of EVs as therapeutic agents for cartilage repair.

Indexed as

cartilage repairchondrocyteexosomesextracellular vesiclesstem celltherapeutic strategies

Identifiers

PMID35070356
PMCPMC8765097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.